Literature DB >> 33478000

The Association between Serum Vitamin D Levels and Helicobacter pylori Presence and Eradication.

Asher Shafrir1,2, Michal Shauly-Aharonov3,4, Lior H Katz2, Ora Paltiel4,5, Yishai Pickman6, Zvi Ackerman7.   

Abstract

BACKGROUND: The success of Helicobacter pylori (H. pylori) eradication depends on several host and treatment factors. Serum vitamin D levels may be associated with H. pylori infection and eradication rates. We investigated the association between vitamin D and H. pylori infection and eradication, using a large electronic database based on medical records from a population-based health maintenance organization.
METHODS: Data regarding adults who underwent H. pylori testing and had vitamin D measurements within one month of H. pylori testing were collected. H. pylori infection was ascertained using urea breath or stool antigen tests. A negative H. pylori test following a positive result implied eradication. Multivariate regression models were constructed to assess associations between H. pylori infection, eradication, and vitamin D.
RESULTS: Among 150,483 members who underwent H. pylori testing from 2009 to 2018, 27,077 (18%) had vitamin D measurements. Vitamin D levels were inversely associated with H. pylori infection, p < 0.001. The odds of a positive H. pylori test were 31% higher among patients with vitamin D levels <20 ng/mL, compared with those with levels ≥20 ng/mL (OR 1.31, 99% CI 1.22-1.4, p < 0.001). Purchase of vitamin D supplements was associated with a negative subsequent H. pylori test (p < 0.001). Mean vitamin D levels were moderately higher in those with successful vs. failed H. pylori eradication (19.34 ± 9.55 vs. 18.64 ± 9.61, p < 0.001).
CONCLUSIONS: Vitamin D levels are associated with H. pylori infection. Increased vitamin D levels are associated with successful H. pylori eradication. Vitamin D may have a role in H. pylori eradication.

Entities:  

Keywords:  25-hydroxyvitamin D2; Helicobacter pylori eradication; Helicobacter pylori infection; Israel; vitamin D

Year:  2021        PMID: 33478000      PMCID: PMC7835846          DOI: 10.3390/nu13010278

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  36 in total

1.  Interaction among ethnicity, socioeconomic status, and Helicobacter pylori seroprevalence in Israeli children and adolescents.

Authors:  Khitam Muhsen; Avishag Nir; Anya Spungin-Bialik; Ravit Bassal; Sophy Goren; Dani Cohen
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-11       Impact factor: 2.839

Review 2.  Factors influencing vitamin D status.

Authors:  William G Tsiaras; Martin A Weinstock
Journal:  Acta Derm Venereol       Date:  2011-03       Impact factor: 4.437

Review 3.  Use of pharmacy records to measure treatment adherence: a critical review of the literature.

Authors:  Elisangela da Costa Lima-Dellamora; Claudia Garcia Serpa Osorio-de-Castro; Livia Gonçalves Dos Santos Lima Madruga; Thiago Botelho Azeredo
Journal:  Cad Saude Publica       Date:  2017-04-20       Impact factor: 1.632

4.  ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.

Authors:  William D Chey; Grigorios I Leontiadis; Colin W Howden; Steven F Moss
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

Review 5.  Epidemiology of Helicobacter pylori infection and public health implications.

Authors:  Alexander C Ford; Anthony T R Axon
Journal:  Helicobacter       Date:  2010-09       Impact factor: 5.753

Review 6.  Unique responses of Helicobacter pylori to exogenous hydrophobic compounds.

Authors:  Hirofumi Shimomura; Kiyofumi Wanibuchi; Kouichi Hosoda; Avarzed Amgalanbaatar; Hisashi Masui; Takashi Takahashi; Yoshikazu Hirai
Journal:  Chem Phys Lipids       Date:  2020-04-04       Impact factor: 3.329

7.  Indene Compounds Synthetically Derived from Vitamin D Have Selective Antibacterial Action on Helicobacter pylori.

Authors:  Kiyofumi Wanibuchi; Kouichi Hosoda; Masato Ihara; Kentaro Tajiri; Yuki Sakai; Hisashi Masui; Takashi Takahashi; Yoshikazu Hirai; Hirofumi Shimomura
Journal:  Lipids       Date:  2018-05-16       Impact factor: 1.880

8.  Critical Role of Antimicrobial Peptide Cathelicidin for Controlling Helicobacter pylori Survival and Infection.

Authors:  Lin Zhang; William K K Wu; Richard L Gallo; Evandro F Fang; Wei Hu; Thomas K W Ling; Jing Shen; Ruby L Y Chan; Lan Lu; Xiao M Luo; Ming X Li; Kam M Chan; Jun Yu; Vincent W S Wong; Siew C Ng; Sunny H Wong; Francis K L Chan; Joseph J Y Sung; Matthew T V Chan; Chi H Cho
Journal:  J Immunol       Date:  2016-01-22       Impact factor: 5.422

Review 9.  Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis.

Authors:  Bao-Zhu Li; Diane Erin Threapleton; Ji-Yao Wang; Jian-Ming Xu; Jin-Qiu Yuan; Chao Zhang; Peng Li; Qian-Ling Ye; Biao Guo; Chen Mao; Dong-Qing Ye
Journal:  BMJ       Date:  2015-08-19

Review 10.  Systematic review of the relationship of Helicobacter pylori infection with geographical latitude, average annual temperature and average daily sunshine.

Authors:  Chao Lu; Ye Yu; Lan Li; Chaohui Yu; Ping Xu
Journal:  BMC Gastroenterol       Date:  2018-04-17       Impact factor: 3.067

View more
  3 in total

1.  Association of hypertension with helicobacter pylori: A systematic review and meta‑analysis.

Authors:  Yizhen Fang; Huabin Xie; Chunming Fan
Journal:  PLoS One       Date:  2022-05-19       Impact factor: 3.752

Review 2.  The Effects of Vitamins and Micronutrients on Helicobacter pylori Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System.

Authors:  Ali Nabavi-Rad; Mahsa Azizi; Shaghayegh Jamshidizadeh; Amir Sadeghi; Hamid Asadzadeh Aghdaei; Abbas Yadegar; Mohammad Reza Zali
Journal:  J Immunol Res       Date:  2022-03-16       Impact factor: 4.818

3.  Vitamins and Helicobacter pylori: An Updated Comprehensive Meta-Analysis and Systematic Review.

Authors:  Xianlei Cai; Xueying Li; Yangli Jin; Miaozun Zhang; Yuan Xu; Chao Liang; Yihui Weng; Weiming Yu; Xiuyang Li
Journal:  Front Nutr       Date:  2022-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.